Blue Bell Private Wealth Management’s Nuveen Tax-Advantaged Total Return Strategy Fund JTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-800
Closed -$10K 266
2017
Q2
$10K Sell
800
-2,640
-77% -$33.2K 0.01% 188
2017
Q1
$42K Hold
3,440
0.02% 135
2016
Q4
$39K Sell
3,440
-800
-19% -$9.13K 0.02% 142
2016
Q3
$51K Sell
4,240
-10,242
-71% -$122K 0.03% 206
2016
Q2
$164K Buy
14,482
+9,180
+173% +$104K 0.11% 100
2016
Q1
$60K Buy
5,302
+2,631
+99% +$28.1K 0.04% 203
2015
Q4
$31K Sell
2,671
-1,539
-37% -$18.3K 0.02% 264
2015
Q3
$47K Buy
4,210
+700
+20% +$8.75K 0.03% 224
2015
Q2
$46K Buy
3,510
+2,397
+215% +$32.7K 0.03% 232
2015
Q1
$15K Sell
1,113
-8,820
-89% -$118K 0.01% 342
2014
Q4
$132K Buy
+9,933
New +$132K 0.08% 130

Other funds holding JTA

Blue Bell Private Wealth Management's JTA Position: Q3 2017 in Review

Blue Bell Private Wealth Management sold out of Nuveen Tax-Advantaged Total Return Strategy Fund (JTA) in Q3 2017, closing a stake of 800 shares — an estimated $10K sold.

Blue Bell Private Wealth Management first reported a position in JTA in Q4 2014 and held it in 11 quarters. The position peaked at $164K in Q2 2016. 28 funds tracked by Wall St. Rank hold JTA as of Q3 2017.

  • Blue Bell Private Wealth Management reported no remaining Nuveen Tax-Advantaged Total Return Strategy Fund position as of Q3 2017 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 800 Nuveen Tax-Advantaged Total Return Strategy Fund shares in Q3 2017, an estimated $10K.
  • Blue Bell Private Wealth Management first reported a position in Nuveen Tax-Advantaged Total Return Strategy Fund in Q4 2014 and held it in 11 quarters.
  • Blue Bell Private Wealth Management's Nuveen Tax-Advantaged Total Return Strategy Fund position peaked at $164K in Q2 2016.
  • 28 funds tracked by Wall St. Rank held Nuveen Tax-Advantaged Total Return Strategy Fund as of Q3 2017.

Based on Blue Bell Private Wealth Management's 13F filing for Q3 2017, filed 24 Oct 2017.